Social adjustment in children diagnosed with sickle cell disease: A retrospective study.

blood disorder pediatrics psychosocial sickle cell disease

Journal

Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624

Informations de publication

Date de publication:
18 Dec 2023
Historique:
revised: 29 10 2023
received: 21 06 2023
accepted: 27 11 2023
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: aheadofprint

Résumé

Children with sickle cell disease (SCD) are at risk for physical, psychological, and social adjustment challenges. This study sought to investigate social adjustment and related factors in children living with SCD. Data from 32 children (50% male, mean age = 10.32 years, SD = 3.27) were retrospectively collected from a neuropsychology clinic at a tertiary care pediatric hospital. Social adjustment was measured using the Behavior Assessment System for Children (BASC-3) parent-proxy, withdrawal subscale, and the Pediatric Quality of Life Inventory (PedsQL) Generic Module Social Functioning self- and parent-proxy subscales. Other measures captured executive functioning (i.e., Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) Parent Form) and non-disease-related associations with social adjustment, including number of years in Canada and family functioning (i.e., PedsQL Family Impact Module). Sixteen percent of patients reported elevated social adjustment difficulties. Multiple linear regression found better family functioning [B = .48, t = 2.65, p = .016], and higher executive functioning [B = -.43, t = -2.39, p = .028] were related to higher scores on the PedsQL parent-proxy ratings of social adjustment [F(4,18) = 5.88, p = .003]. Male sex [B = .54, t = 3.08, p = .005], and having lived more years in Canada [B = .55, t = 2.81, p = .009], were related to higher PedsQL self-reported social adjustment [F(4,23) = 3.75, p = .017]. The model examining the BASC-3 withdrawal subscale was not statistically significant [F(4,16) = 1.63, p = .22]. Social adjustment in children diagnosed with SCD warrants future research to understand the influence of executive function, and non-disease-related factors, particularly focusing on sociocultural factors.

Sections du résumé

BACKGROUND BACKGROUND
Children with sickle cell disease (SCD) are at risk for physical, psychological, and social adjustment challenges. This study sought to investigate social adjustment and related factors in children living with SCD.
METHODS METHODS
Data from 32 children (50% male, mean age = 10.32 years, SD = 3.27) were retrospectively collected from a neuropsychology clinic at a tertiary care pediatric hospital. Social adjustment was measured using the Behavior Assessment System for Children (BASC-3) parent-proxy, withdrawal subscale, and the Pediatric Quality of Life Inventory (PedsQL) Generic Module Social Functioning self- and parent-proxy subscales. Other measures captured executive functioning (i.e., Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) Parent Form) and non-disease-related associations with social adjustment, including number of years in Canada and family functioning (i.e., PedsQL Family Impact Module).
RESULTS RESULTS
Sixteen percent of patients reported elevated social adjustment difficulties. Multiple linear regression found better family functioning [B = .48, t = 2.65, p = .016], and higher executive functioning [B = -.43, t = -2.39, p = .028] were related to higher scores on the PedsQL parent-proxy ratings of social adjustment [F(4,18) = 5.88, p = .003]. Male sex [B = .54, t = 3.08, p = .005], and having lived more years in Canada [B = .55, t = 2.81, p = .009], were related to higher PedsQL self-reported social adjustment [F(4,23) = 3.75, p = .017]. The model examining the BASC-3 withdrawal subscale was not statistically significant [F(4,16) = 1.63, p = .22].
IMPLICATIONS CONCLUSIONS
Social adjustment in children diagnosed with SCD warrants future research to understand the influence of executive function, and non-disease-related factors, particularly focusing on sociocultural factors.

Identifiants

pubmed: 38110802
doi: 10.1002/pbc.30807
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e30807

Subventions

Organisme : Alberta Children's Hospital Research Institute
Organisme : Charbonneau Cancer Research Institue

Informations de copyright

© 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.

Références

World Health Organizaton. Sickle cell disease. WHO, Regional Office for Africa; 2020. Accessed February 3, 2021. https://www.afro.who.int/health-topics/sickle-cell-disease
Chen H. Atlas of Genetic Diagnosis and Counseling. Springer New York; 2012.
Day SW, Wynn LW. Sickle cell pain & hydroxyurea. Am J Nurs. 2000;100(11):34-39. doi:10.1097/00000446-200011000-00041
Yeates KO, Bigler ED, Dennis M, et al. Social outcomes in childhood brain disorder: a heuristic integration of social neuroscience and developmental psychology. Psychol Bull. 2007;133(3):535-556. doi:10.1037/0033-2909.133.3.535
Noll RB, Vannatta K, Koontz K, Kalinyak K, Bukowski WM, Davies WH. Peer relationships and emotional well-being of youngsters with sickle cell disease. Child Dev. 1996;67(2):423-436.
Noll RB, Vannatta K, Koontz K, Kalinyak K, Bukowski WM, Davies WH. Peer relationships and emotional well-being of youngsters with sickle cell disease. Child Dev. 1996;67(2):423-436.
Bediako SM, Moffitt KR. Race and social attitudes about sickle cell disease. Ethn Health. 2011;16(4-5):423-429. doi:10.1080/13557858.2011.552712
Dunn JR, Dyck I. Social determinants of health in Canada's immigrant population: results from the National Population Health Survey. Soc Sci Med. 2000;51(11):1573-1593. doi:10.1016/S0277-9536(00)00053-8
Braveman PA, Cubbin C, Egerter S, Williams DR, Pamuk E. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100(S1):S186-S196. doi:10.2105/AJPH.2009.166082
Güngör D, Strohmeier D. Contextualizing Immigrant and Refugee Resilience: Cultural and Acculturation Perspectives. 1st ed. Springer International Publishing; 2020. doi:10.1007/978-3-030-42303-2
Schulte F, Brinkman TM, Li C, et al. Social adjustment in adolescent survivors of pediatric central nervous system tumors: a report from the Childhood Cancer Survivor Study. Cancer. 2018;124(17):3596-3608. doi:10.1002/cncr.31593
Barkley RA. Executive Functions What They Are, How They Work, and Why They Evolved. 1st ed. Guilford Press; 2012.
Steen RG, Langston JW, Reddick WE, Ogg R, Chen G, Wang WC. Quantitative MR imaging of children with sickle cell disease: striking T1 elevation in the thalamus. J Magn Reson Imaging. 1996;6(1):226-234. doi:10.1002/jmri.1880060140
Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH. Sickle cell disease. Hematology. 2004;2004(1):35-47. doi:10.1182/asheducation-2004.1.35
Adolphs R. The neurobiology of social cognition. Curr Opin Neurobiol. 2001;11(2):231-239.
Prussien KV, Jordan LC, DeBaun MR, Compas BE. Cognitive function in sickle cell disease across domains, cerebral infarct status, and the lifespan: a meta-analysis. J Pediatr Psychol. 2019;44(8):948-958. https://dx.doi.org/10.1093/jpepsy/jsz031
Jonassaint CR, Jones VL, Leong S, Frierson GM. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haematol. 2016;174(1):136-147. doi:10.1111/bjh.14023
McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50.
Schatz J, White DA, Moinuddin A, Armstrong M, DeBaun MR. Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol. 2002;17(12):890-894. doi:10.1177/08830738020170122401
Schulte FSM, Merz EL, Russell KB, et al. Social adjustment in survivors of acute lymphoblastic leukemia without cranial radiation therapy. Pediatr Blood Cancer. 2022;69(1):e29407. doi:10.1002/pbc.29407
Reynolds CR, Kamphaus R. Behavior Assessment System for Children, Third Edition (BASC-3). Pearson; 2015.
Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory Version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800-812. doi:10.1097/00005650-200108000-00006
Wolfe-Christensen C, Mullins L, Stinnett T, Carpentier M, Fedele D. Use of the Behavioral Assessment System for Children 2nd Edition: parent report scale in pediatric cancer populations. J Clin Psychol Med Settings. 2009;16(4):322-330.
Peterson RK, Williams S, Janzen L. Cognitive correlates of math performance in school-aged children with sickle cell disease and silent cerebral infarcts. Arch Clin Neuropsychol. 2021;36(4):465-474. doi:10.1093/arclin/acaa071
Karkoska K, Zaheer S, Chen V, Fishbein J, Appiah-Kubi A, Aygun B. A pilot study to screen for poor academic performance in children with sickle cell disease in the outpatient setting. Pediatr Blood Cancer. 2020;67(5):e28196. doi:10.1002/pbc.28196
Hocking MC, McCurdy M, Turner E, et al. Social competence in pediatric brain tumor survivors: application of a model from social neuroscience and developmental psychology. Pediatr Blood Cancer. 2015;62(3):375-384. doi:10.1002/pbc.25300
Panepinto JA, Pajewski NM, Foerster LM, Hoffmann RG. The performance of the pedsQL generic core scales in children with sickle cell disease. J Pediatr Hematol Oncol. 2008;30(9):666-673. doi:10.1097/MPH.0b013e31817e4a44
McClellan CB, Schatz J, Sanchez C, Roberts CW. Validity of the pediatric quality of life inventory for youth with sickle cell disease. J Pediatr Psychol. 2008;33(10):1153-1162. doi:10.1093/jpepsy/jsn036
Gioia G, Isquith P, Guy S, Kenworthy L. Behavior Rating Inventory of Executive Functions, Second Edition (BRIEF-2) Manual. Florida: Psychological Assessment Resources Inc; 2000.
McCauley SR, Wilde EA, Anderson VA, et al. Recommendations for the use of common outcome measures in pediatric traumatic brain injury research. J Neurotrauma. 2012;29(4):678-705. doi:10.1089/neu.2011.1838
Hardy SJ, Bills SE, Wise SM, Hardy KK. Cognitive abilities moderate the effect of disease severity on health-related quality of life in pediatric sickle cell disease. J Pediatr Psychol. 2018;43(8):882-894.
Okocha EC, Manafa OP, Aneke CJ, Onwuzuruike EC, Ibeh CN, Chukwuma OG. Serum superoxide dismutase activity: a predictor of disease severity in nigerian sickle cell anemia patients in steady state. Med J Dr DY Patil Univ. 2017;10(5):406-411.
Kutlar A, Kanter J, Liles DK, et al. Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: a SUSTAIN study analysis. Am J Hematol. 2019;94(1):55-61. doi:10.1002/ajh.25308
Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The PedsQL Family Impact Module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55. doi:10.1186/1477-7525-2-55
Panepinto JA, Hoffmann RG, Pajewski NM. A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease. Health Qual Life Outcomes. 2009;7(1):32. doi:10.1186/1477-7525-7-32
IBM Corp. IBM SPSS Statistics for Windows, Version 27.0. IBM Corp.
Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: a Regression-Based Approach. 3rd ed. The Guilford Press; 2022.
da Guarda CC, Yahouédéhou SCMA, Santiago RP, et al. Sickle cell disease: a distinction of two most frequent genotypes (HbSS and HbSC). PLoS One. 2020;15(1):e0228399. doi:10.1371/journal.pone.0228399
Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3(6):329-341. doi:10.1367/1539-4409(2003)003<0329:tpaapp>2.0.co;2
Noll RB, Ris Douglas M, Davies Hobart W, Bukowski MW, Koontz MK. Social Interactions between children with cancer or sickle cell disease and their peers: teacher ratings. J Dev Behav Pediatr. 1992;13(3):187-193.
Meier ER, Abraham A, Fasano RM. Sickle Cell Disease and Hematopoietic Stem Cell Transplantation. Springer International Publishing; 2017.
Szczepura A. Access to health care for ethnic minority populations. Postgrad Med J. 2005;81(953):141-147. doi:10.1136/pgmj.2004.026237
Gibbons CL, Mangen MJJ, Plass D, et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health. 2014;14:147. doi:10.1186/1471-2458-14-147
Novo R, Gonzalez B, Roberto M. Beyond personality: underreporting in high-stakes assessment contexts. Pers Individ Dif. 2022;184:111190. doi:10.1016/j.paid.2021.111190
Ingerski L, Modi A, Hood K, et al. Health-related quality of life across pediatric chronic conditions. J Pediatr. 2010;156(4):639-644. doi:10.1016/j.jpeds.2009.11.008
Boni LC, Brown RT, Davis PC, Hsu L, Hopkins K. Social information processing and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol. 2001;26(5):309-319.
Kral M, Brown R, Hynd G. Neuropsychological aspects of pediatric sickle cell disease. Neuropsychol Rev. 2001;11(4):179-196.
Masten AS, Morison P, Pellegrini DS. A revised class play method of peer assessment. Dev Psychol. 1985;21(3):523-533. doi:10.1037/0012-1649.21.3.523
Keenan ME, Loew M, Berlin KS, et al. Empirically derived profiles of health-related quality of life in youth and young adults with sickle cell disease. J Pediatr Psychol. 2021;46(3):293-303. doi:10.1093/jpepsy/jsaa104
Lim CS, Karlson C, Edmond SN, Welkom JS, Osunkwo I, Cohen LL. Emotion-focused avoidance coping mediates the association between pain and health-related quality of life in children with sickle cell disease. J Pediatr Hematol Oncol. 2019;41(3):194-201. doi:10.1097/MPH.0000000000001429
Blake A, Guthrie-Dixon N, Grindley M, Barton-Gooden A, Knight-Madden J, Asnani M. Level of agreement between adolescents’ self-assessment and parent proxy report of health-related quality of life in adolescents with sickle cell disease. Pediatr Blood Cancer. 2020;67(4):e28198. doi:10.1002/pbc.28198
Kambasu DM, Rujumba J, Lekuya HM, Munube D, Mupere E. Health-related quality of life of adolescents with sickle cell disease in sub-Saharan Africa: a cross-sectional study. BMC Hematol. 2019;19:9. doi:10.1186/s12878-019-0141-8
Stokoe M, Zwicker HM, Forbes C, et al. Health related quality of life in children with sickle cell disease: a systematic review and meta-analysis. Blood Rev. 2022;56:100982. doi:10.1016/j.blre.2022.100982
Panepinto JA, Foerster LM. Disease severity in sickle cell disease: understanding impairment in health-related quality of life. Blood. 2007;110(11):957. doi:10.1182/blood.V110.11.957.957
Iliyasu Z, Borodo AM, Jibir BW, Nass NS, Aliyu MH. A child with sickle cell disease can't live with just anyone. A mixed methods study of socio-behavioral influences and severity of sickle cell disease in northern Nigeria. Health Sci Rep. 2021;4(1):e222. doi:10.1002/hsr2.222
Sehlo MG, Kamfar HZ. Depression and quality of life in children with sickle cell disease: the effect of social support. BMC Psychiatry. 2015;15:78. doi:10.1186/s12888-015-0461-6
Belhadj Kouider E, Koglin U, Petermann F. Emotional and behavioral problems in migrant children and adolescents in American countries: a systematic review. J Immigr Minor Health. 2015;17(4):1240-1258. doi:10.1007/s10903-014-0039-2
Böhlmark A. Integration of childhood immigrants in the short and long run: Swedish evidence. Int Migr Rev. 2009;43(2):387-409. doi:10.1111/j.1747-7379.2009.00769.x
Klassen AF, Gulati S, Watt L, et al. Immigrant to Canada, newcomer to childhood cancer: a qualitative study of challenges faced by immigrant parents. Psychooncology. 2012;21(5):558-562. doi:10.1002/pon.1963
Lim CS, Welkom JS, Cohen LL, Osunkwo I. Evaluating the protective role of racial identity in children with sickle cell disease. J Pediatr Psychol. 2012;37(8):832-842. doi:10.1093/jpepsy/jss059
Abraham A, Jacobsohn DA, Bollard CM. Cellular therapy for sickle cell disease. Cytotherapy. 2016;18(11):1360-1369.
Kawadler JM, Kirkham FJ, Clayden JD, et al. White matter damage relates to oxygen saturation in children with sickle cell anemia without silent cerebral infarcts. Stroke. 2015;46(7):1793-1799. doi:10.1161/STROKEAHA.115.008721
Wang W, Enos L, Gallagher D, et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):391-397.

Auteurs

Hailey M Zwicker (HM)

Hematology, Oncology, Transplant Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Taryn B Fay-McClymont (TB)

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Neuropsychology Services, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Psychology, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.

Sharon H J Hou (SHJ)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Psychology, BC Children's Hospital, Vancouver, British Columbia, Canada.

Sara Cho (S)

Hematology, Oncology, Transplant Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Kaelyn McDonald (K)

Hematology, Oncology, Transplant Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Gregory M T Guilcher (GMT)

Hematology, Oncology, Transplant Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Keith O Yeates (KO)

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Neuropsychology Services, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Psychology, Faculty of Arts, University of Calgary, Calgary, Alberta, Canada.

Brian L Brooks (BL)

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Neuropsychology Services, Alberta Children's Hospital, Calgary, Alberta, Canada.
Child Brain and Mental Health, Alberta Children's Hospital Research Institute, Alberta Children's Hospital, Calgary, Alberta, Canada.

Fiona S M Schulte (FSM)

Hematology, Oncology, Transplant Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Classifications MeSH